Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹25 Cr.
Stock P/E
4.9
P/B
0.6
Current Price
₹24.7
Book Value
₹ 42.8
Face Value
10
52W High
₹43
52W Low
₹ 20.6
Dividend Yield
0%

Medico Intercont. Overview

Business

Medico Intercontinental Ltd. (MIL) operates in the Trading sector, specifically within the Trading industry in India. As a trading company, MIL's core business involves sourcing various goods or commodities from suppliers and distributing them to customers, often across different geographies or market segments. The company typically acts as an intermediary, facilitating transactions and managing logistics, inventory, and potentially financing. It makes money primarily through the margins achieved on the goods traded (buying at a lower price and selling at a higher price) and may also earn commission or fees for its distribution and supply chain services.

Revenue Mix

Specific key segments and their revenue contributions for Medico Intercontinental Ltd. are not publicly available or provided. However, a typical trading company may segment its business by:

Product Category (e.g., specific types of goods traded)

Geographic Market (e.g., domestic trading vs. international export/import)

Customer Type (e.g., B2B wholesale, institutional clients)

Without specific data, it is not possible to detail MIL's precise revenue mix.

Industry

The trading industry in India is diverse and often fragmented, encompassing a wide range of products from raw materials and industrial goods to consumer products. It is characterized by intense competition, reliance on efficient supply chain management, access to capital, and strong relationships with both suppliers and customers. A company's positioning within this industry largely depends on its specific product niches, geographical reach, operational scale, logistical capabilities, and ability to manage inventory and credit risks effectively. Without specific operational details, MIL's precise positioning relative to its peers cannot be determined, but it likely competes on factors like price, reliability, and service in its chosen trading segments.

MOAT

For a trading company like MIL, potential competitive advantages (moats) are often derived from:

Strong Supplier & Customer Relationships: Long-standing, exclusive, or preferential agreements can provide stable supply and demand.

Efficient Supply Chain & Logistics: Superior operational efficiency in sourcing, warehousing, and distribution can lead to cost advantages and faster delivery.

Market Intelligence & Expertise: Deep understanding of specific product markets, including pricing trends, demand patterns, and regulatory landscapes.

Capital Strength & Credit Lines: Ability to fund large inventory purchases and extend credit to customers, which can be crucial in high-volume trading.

Niche Specialization: Focusing on specific, high-barrier-to-entry products or geographies where competition is less intense.

The existence and strength of these advantages for MIL specifically are not detailed.

Growth Drivers

Key factors that could drive growth for MIL over the next 3-5 years include:

Economic Growth in India: General economic expansion will likely increase demand for goods and commodities, driving trading volumes.

Expansion into New Product Categories: Diversifying the product portfolio to capture new market opportunities.

Geographic Expansion: Venturing into new domestic regions or international markets to broaden reach.

Supply Chain Optimization & Digitalization: Improving operational efficiency, reducing costs, and enhancing service through technology adoption.

Strategic Partnerships: Collaborating with large manufacturers or distributors to expand distribution networks.

Government Initiatives: Policies promoting trade, manufacturing, or specific sectors where MIL operates.

Risks

Medico Intercontinental Ltd. faces several inherent risks common to the trading industry:

Commodity Price Volatility: Significant fluctuations in the prices of goods traded can erode margins or lead to inventory losses.

Currency Fluctuations: If involved in international trade, adverse movements in exchange rates can impact profitability.

Supply Chain Disruptions: Geopolitical events, natural disasters, or logistical bottlenecks can disrupt supply and distribution.

Credit Risk: Risk of default by customers on payments, especially in large-volume, credit-based transactions.

Intense Competition: The trading industry is highly competitive, leading to pressure on margins.

Inventory Management Risk: Risk of obsolescence, damage, or holding excess inventory during price declines.

Regulatory & Trade Policy Changes: Changes in import/export duties, tariffs, or trade regulations can impact business operations and profitability.

Management & Ownership

Specific details regarding the promoters, management quality, and detailed ownership structure of Medico Intercontinental Ltd. are not available. In India, many companies, especially in this sector, are often promoter-led, meaning the founding family or individuals hold significant ownership and control, influencing strategic direction and operational decisions.

Outlook

Medico Intercontinental Ltd., as a trading company, operates in an essential but often competitive segment of the Indian economy. Its future performance will largely depend on its ability to effectively navigate market dynamics, manage supply chain efficiencies, and identify profitable trading niches.

Bull Case: If MIL can capitalize on India's economic growth, expand strategically into high-demand product categories or geographies, and maintain robust supplier and customer relationships while optimizing its operational costs, it could achieve consistent growth and profitability.

Bear Case: The company faces risks from volatile commodity prices, intense competition, potential supply chain disruptions, and credit risks. Failure to adapt to changing market conditions or to efficiently manage its inventory and working capital could lead to margin erosion and subdued performance. The outlook remains balanced, contingent on effective risk management, operational excellence, and strategic market positioning within the dynamic Indian trading landscape.

Medico Intercont. Share Price

Live · BSE · Inception: 1984
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

Medico Intercont. Quarterly Results

#(Fig in Cr.) Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 16 19 36 18 21 21 20 20 22 21
Other Income 0 0 0 0 0 0 1 0 0 0
Total Income 16 19 37 19 21 22 21 20 23 21
Total Expenditure 14 18 34 17 19 21 21 18 21 21
Operating Profit 2 2 3 2 2 1 -0 2 2 -1
Interest 0 0 0 0 0 2 2 2 2 2
Depreciation 0 0 0 0 0 1 2 1 1 1
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 1 1 2 2 1 -2 -4 -1 -2 -4
Provision for Tax 0 0 1 0 0 0 0 0 1 0
Profit After Tax 1 1 2 1 1 -3 -5 -2 -2 -4
Adjustments 0 0 0 0 0 2 3 1 2 3
Profit After Adjustments 1 1 2 1 1 -1 -2 -0 -1 -1
Adjusted Earnings Per Share 1 1.1 1.6 1.2 1.2 -0.7 -1.7 -0.2 -0.7 -1.4

Medico Intercont. Profit & Loss

#(Fig in Cr.) Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 0 10 82 70 74 76 71 96 83
Other Income 0 0 0 0 0 1 0 0 1
Total Income 0 10 82 70 75 77 72 96 85
Total Expenditure 0 9 78 65 69 71 66 88 81
Operating Profit 0 1 4 5 5 6 6 9 3
Interest 0 0 1 1 1 1 0 1 8
Depreciation 0 0 0 0 0 0 0 1 5
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0
Profit Before Tax 0 1 3 4 4 5 5 7 -11
Provision for Tax 0 0 1 1 1 1 1 2 1
Profit After Tax 0 1 2 3 3 4 4 5 -13
Adjustments 0 0 0 0 0 0 0 0 9
Profit After Adjustments 0 1 2 3 3 4 4 5 -4
Adjusted Earnings Per Share 0.1 2.3 7.3 7.9 9.5 3.6 3.9 5.1 -4

Medico Intercont. Balance Sheet

#(Fig in Cr.) Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 3 4 6 10 13 41 45 49
Minority's Interest 0 0 0 0 0 0 0 0
Borrowings 0 0 13 7 6 2 2 13
Other Non-Current Liabilities -0 -0 0 0 0 0 0 1
Total Current Liabilities 1 5 17 15 13 15 9 13
Total Liabilities 4 9 36 31 32 59 56 76
Fixed Assets 0 0 2 2 2 3 4 5
Other Non-Current Assets 2 1 0 0 1 7 14 14
Total Current Assets 1 8 34 28 28 50 38 57
Total Assets 4 9 36 31 32 59 56 76

Medico Intercont. Cash Flow

#(Fig in Cr.) Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 0 1 1 1 2 7 3
Cash Flow from Operating Activities 0 1 -14 6 4 -10 6 -7
Cash Flow from Investing Activities 0 0 -4 -1 -1 -5 -9 -2
Cash Flow from Financing Activities 0 0 17 -5 -1 20 -0 9
Net Cash Inflow / Outflow 0 1 -0 -0 1 5 -3 -1
Closing Cash & Cash Equivalent 0 1 1 1 2 7 3 3

Medico Intercont. Ratios

# Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 0.09 2.27 7.25 7.93 9.54 3.61 3.95 5.06
CEPS(Rs) 0.1 2.28 7.58 8.35 10.17 3.81 4.23 5.87
DPS(Rs) 0 0 0 0 0 0.1 0 0
Book NAV/Share(Rs) 10.06 12.32 19.58 29.35 38.89 41.19 45.03 48.65
Core EBITDA Margin(%) 0 7.03 5.38 6.84 6.74 6.9 8.16 8.77
EBIT Margin(%) 0 10.57 5.31 6.9 6.88 7.3 8.32 8.3
Pre Tax Margin(%) 0 10.11 3.91 5.06 5.7 6.49 7.62 7.26
PAT Margin (%) 0 7.39 2.88 3.69 4.17 4.73 5.53 5.27
Cash Profit Margin (%) 0 7.43 3 3.89 4.45 5 5.93 6.11
ROA(%) 0.76 11.32 10.44 7.73 9.91 7.95 6.87 7.67
ROE(%) 0.9 20.24 45.48 32.41 27.96 13.41 9.16 10.8
ROCE(%) 1.41 28.42 36.08 25 25.69 16.57 12.39 13.81
Receivable days 0 143.01 65.1 106.63 86.31 119.69 143.37 106.56
Inventory Days 0 23.16 20.73 46.55 41.76 40.12 49.41 37.41
Payable days 1041.76 113.07 49.68 77.67 56.77 57.89 52.86 29.29
PER(x) 169.79 51.93 2.14 3.23 6.1 22.99 10.09 7.01
Price/Book(x) 1.53 9.55 0.79 0.87 1.5 2.01 0.88 0.73
Dividend Yield(%) 0 0 0 0 0 0.12 0 0
EV/Net Sales(x) 0 3.73 0.22 0.24 0.35 1.06 0.58 0.52
EV/Core EBITDA(x) 98.19 35.2 4.02 3.39 4.83 14.02 6.64 5.66
Net Sales Growth(%) 0 0 723.49 -14.91 6.48 2.65 -6.39 34.56
EBIT Growth(%) 0 2172.55 313.76 10.56 6.09 8.99 6.63 34.31
PAT Growth(%) 0 2397.14 220.21 9.31 20.32 16.4 9.39 28.13
EPS Growth(%) 0 2397.68 220.2 9.31 20.32 -62.18 9.39 28.13
Debt/Equity(x) 0.01 0.03 2.15 0.94 0.68 0.11 0.11 0.35
Current Ratio(x) 2.42 1.66 2.05 1.93 2.17 3.24 4.28 4.43
Quick Ratio(x) 2.42 1.53 1.53 1.31 1.56 2.66 3.12 3.71
Interest Cover(x) 4635.5 22.66 3.78 3.76 5.83 8.94 11.94 7.98
Total Debt/Mcap(x) 0 0 2.7 1.08 0.46 0.06 0.12 0.48

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +35% +9% +3% —
Operating Profit CAGR +50% +22% +18% —
PAT CAGR +25% +19% +20% —
Share Price CAGR -27% -34% -11% —
ROE Average +11% +11% +19% +20%
ROCE Average +14% +14% +19% +20%

Medico Intercont. Shareholding Pattern

Latest · Sep 2026
100% held
Promoters 58.51 %
FII 0 %
DII (MF + Insurance) 0 %
Public (retail) 41.49 %
# Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Promoter 55.0855.0855.1755.1755.1755.1757.1557.1558.5158.51
FII 0000000000
DII 0000000000
Public 44.9244.9244.8344.8344.8344.8342.8542.8541.4941.49
Others 0000000000
Total 100100100100100100100100100100

Medico Intercont. Peer Comparison

Medico Intercont. Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Medico Intercont. Pros & Cons

Pros

  • Stock is trading at 0.6 times its book value
  • Debtor days have improved from 52.86 to 29.29days.
  • Company is almost debt free.

Cons

  • Company has a low return on equity of 11% over the last 3 years.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp